Trimebutine attenuates high mobility group box 1–receptor for advanced glycation end-products inflammatory signaling pathways von Nakajima, Shingo, Ogawa, Natsumi, Yokoue, Natsuki, Tachibana, Haruki, Tamada, Kenya, Okazawa, Miwa, Sato, Akira, Oyama, Takahiro, Abe, Hideaki, Kamiya, Takanori, Yoshimori, Atsushi, Yoshizawa, Kazumi, Inoue, Shigeaki, Yokomizo, Takehiko, Uchiumi, Fumiaki, Abe, Takehiko, Tanuma, Sei-ichi

Volltext

The release of high mobility group box 1 in apoptosis is triggered by nucleosomal DNA fragmentation von Yamada, Yoichiro, Fujii, Taku, Ishijima, Rei, Tachibana, Haruki, Yokoue, Natsuki, Takasawa, Ryoko, Tanuma, Sei-ichi

Volltext

Trimebutine attenuates high mobility group box 1-receptor for advanced glycation end-products in flammatory signaling pathways von Nakajima, Shingo, Ogawa, Natsumi, Yokoue, Natsuki, Tachibana, Haruki, Tamada, Kenya, Okazawa, Miwa, Sato, Akira, Oyama, Takahiro, Abe, Hideaki, Kamiya, Takanori, Yoshimori, Atsushi, Yoshizawa, Kazumi, Inoue, Shigeaki, Yokomizo, Takehiko, Uchiumi, Fumiaki, Abe, Takehiko, Tanuma, Sei-ichi

Volltext

Trimebutine suppresses Toll-like receptor 2/4/7/8/9 signaling pathways in macrophages von Ogawa, Natsumi, Nakajima, Shingo, Tamada, Kenya, Yokoue, Natsuki, Tachibana, Haruki, Okazawa, Miwa, Oyama, Takahiro, Abe, Hideaki, Yamazaki, Hiroaki, Yoshimori, Atsushi, Sato, Akira, Kamiya, Takanori, Yokomizo, Takehiko, Uchiumi, Fumiaki, Abe, Takehiko, Tanuma, Sei-ichi

Volltext

DR396, an apoptotic DNase γ inhibitor, attenuates high mobility group box 1 release from apoptotic cells von Yamada, Yoichiro, Fujii, Taku, Ishijima, Rei, Tachibana, Haruki, Yokoue, Natsuki, Takasawa, Ryoko, Tanuma, Sei-ichi

Volltext